Laffer Tengler Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11	Closed	-$11.6K	–	314
2024 Q2	$11.6K	Hold	11	–	–	﹤0.01%	307
2024 Q1	$10.6K	Hold	11	–	–	﹤0.01%	299
2023 Q4	$9.66K	Hold	11	–	–	﹤0.01%	272
2023 Q3	$9.05K	Sell	11 -2,443	-100%	-$1.92M	﹤0.01%	281
2023 Q2	$1.76M	Sell	2,454 -52	-2%	-$40.1K	0.47%	73
2023 Q1	$2.06M	Buy	2,506 +86	+4%	+$64.9K	0.56%	68
2022 Q4	$1.75M	Buy	2,420 +90	+4%	+$66.4K	0.5%	66
2022 Q3	$1.61M	Buy	2,330 +43	+2%	+$27.1K	0.59%	69
2022 Q2	$1.35M	Sell	2,287 -43	-2%	-$28K	0.47%	82
2022 Q1	$1.63M	Sell	2,330 -43	-2%	-$27.2K	0.49%	81
2021 Q4	$1.5M	Buy	2,373 +266	+13%	+$164K	0.43%	89
2021 Q3	$1.28M	Buy	2,107 +411	+24%	+$255K	0.37%	103
2021 Q2	$947K	Buy	1,696 +1,269	+297%	+$643K	0.36%	93
2021 Q1	$202K	Buy	427 +47	+12%	+$22.9K	0.08%	154
2020 Q4	$182K	Buy	+380	New	+$205K	0.08%	160
2016 Q2	–	Sell	-4,353	Closed	-$1.57M	–	258
2016 Q1	$1.57M	Buy	+4,353	New	+$1.79M	0.42%	111
2015 Q4	–	Hold	0	–	–	–	42
2015 Q3	–	Sell	-4,353	Closed	-$2.34M	–	48
2015 Q2	$2.22M	Buy	+4,353	New	+$2.12M	0.54%	42